Form 4 for LUCD Lucid Diagnostics Inc.

Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-20 · accession 0001062993-22-019850 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-09-22	2022-09-20	LUCD	Lapidus Stanley	Dir	S - Sale	$1.71	-33.9K	135.5K	-20%	-$57.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common stock	2022-09-20	S	D	17,000	$1.71	152,320	D	—	—	(F2) Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.
2	Common	Common stock	2022-09-20	S	D	16,864	$1.70	135,456	D	—	—	(F2) Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.